Abstract
This study investigates the effect of interferons on the induction of human monocyte secretion of interleukin-1 (IL-1) activity by lipopolysaccharides (LPS). Monocytes do not spontaneously produce IL-1 and the addition of interferons to the culture does not lead to detectable secretion. Addition of LPS alone induces the release of measurable amounts of IL-1 activity. The addition of low doses (1-10 units/ml) of alpha, beta, or gamma interferon to the LPS-stimulated cultures further increases this secretion by 50%. The addition of 1000 units/ml of alpha or beta interferon leads to inhibition of IL-1 release. By contrast, gamma interferon is a dose dependent enhancer of IL-1 release. The effect of gamma interferon is on the production of IL-1 and is not an enhancement of IL-1 activity in the biological assay. Results demonstrate that addition of gamma interferon to monocytes increases the rate of secretion of IL-1 by these cells. Gamma interferon also appears to abrogate the loss in the ability of monocytes to produce IL-1 activity after overnight culture. This last result parallels the maintainence of the expression of the HLA-DR surface marker on monocytes by gamma interferon. These results may help define a mechanism involving IL-1 generation which could have bearing on the in vivo pyrogenic effects of purified gamma interferon.
MeSH Terms
Antigens, Surface/analysis
Cells, Cultured
Dose-Response Relationship, Drug
HLA-DR Antigens
Histocompatibility Antigens Class II/analysis
Humans
In Vitro Techniques
Interferon-gamma/pharmacology
Interferons/pharmacology
Interleukin-1/biosynthesis
Lipopolysaccharides/pharmacology
Monocytes/drug effects,immunology
Time Factors
Chemicals
Antigens, Surface
HLA-DR Antigens
Histocompatibility Antigens Class II
Interleukin-1
Lipopolysaccharides
Interferon-gamma
Interferons
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Newton R C
References (28)
28 references, click to expand
-
Immune interferon induces the receptor for monomeric IgG1 on human monocytic and myeloid cells.
J Exp Med. 1983 Oct 1;158(4):1092-113
PMID: 6225822
-
Antigen presentation: comments on its regulation and mechanism.
J Immunol. 1984 Jan;132(1):1-5
PMID: 6228574
-
Interferon induction and augmentation of natural-killer activity by Staphylococcus protein A.
Cell Immunol. 1981 Jan 1;57(1):1-12
PMID: 6163551
-
Cloned human interferon-gamma, but not interferon-beta or -alpha, induces expression of HLA-DR determinants by fetal monocytes and myeloid leukemic cell lines.
J Immunol. 1984 Jan;132(1):240-5
PMID: 6418799
-
Virus interference. I. The interferon.
Proc R Soc Lond B Biol Sci. 1957 Sep 12;147(927):258-67
PMID: 13465720
-
Interferon-Like Virus-Inhibitor Induced in Human Leukocytes by Phytohemagglutinin.
Science. 1965 Jul 16;149(3681):310-1
PMID: 17838106
-
Lymphokine regulation of activated (G1) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin 2 production.
J Immunol. 1983 Apr;130(4):1770-3
PMID: 6601136
-
Stimulation of pinocytosis in the macrophage by lymphocyte mediators. I. Description of the phenomenon.
Cell Immunol. 1980 Sep 15;55(1):145-54
PMID: 7000370
-
A preliminary Phase I trial of partially purified interferon-gamma in patients with cancer.
J Biol Response Mod. 1984 Dec;3(6):599-607
PMID: 6439828
-
Immunoregulation by gamma-interferon?
Nature. 1982 Oct 28;299(5886):778
PMID: 6182471
-
Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.
J Exp Med. 1983 Sep 1;158(3):670-89
PMID: 6411853
-
Differentiation-associated alteration in human monocyte-macrophage accessory cell function.
J Immunol. 1983 May;130(5):2156-60
PMID: 6300239
-
Human T-cell hybridomas producing migration inhibitory factor and macrophage activating factors.
Cell Immunol. 1983 Jun;78(2):257-65
PMID: 6305517
-
Immune interferon and leukocyte-conditioned medium induce normal and leukemic myeloid cells to differentiate along the monocytic pathway.
J Exp Med. 1983 Dec 1;158(6):2058-80
PMID: 6417261
-
Both the kind and magnitude of stimulus are important in overcoming the negative regulation of macrophage activation by PGE2.
J Leukoc Biol. 1984 Mar;35(3):291-301
PMID: 6423750
-
Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2.
J Immunol. 1981 Mar;126(3):1120-5
PMID: 6161959
-
T-Cell lymphoma model for the analysis of interleukin 1-mediated T-cell activation.
Proc Natl Acad Sci U S A. 1981 Feb;78(2):1133-7
PMID: 6785748
-
Prostaglandins modulate macrophage Ia expression.
Nature. 1982 Sep 9;299(5879):163-5
PMID: 6287286
-
Interferon receptors. Cross-linking of human leukocyte interferon alpha-2 to its receptor on human cells.
J Biol Chem. 1982 Dec 10;257(23):13884-7
PMID: 6292213
-
A regulatory role for interferon in immunity.
Ann N Y Acad Sci. 1979;332:345-55
PMID: 231406
-
Macrophage-dependent activation of antigen-specific T cells requires antigen and a soluble monokine.
J Immunol. 1983 Jul;131(1):23-9
PMID: 6190909
-
Regulation of murine macrophage Ia-antigen expression by products of activated spleen cells.
J Exp Med. 1980 Dec 1;152(6):1734-44
PMID: 6450260
-
Constitutive secretion of interleukin 1 by human monocytes.
Eur J Immunol. 1983 Aug;13(8):647-51
PMID: 6603982
-
Defective interleukin-1 production by monocytes from patients with malignant disease. Interferon increases IL-1 production.
Cancer Immunol Immunother. 1984;16(3):182-5
PMID: 6608404
-
Interferons as modulators of human monocyte-macrophage differentiation. I. Interferon-gamma increases HLA-DR expression and inhibits phagocytosis of zymosan.
J Immunol. 1984 Mar;132(3):1249-54
PMID: 6420462
-
Macrophage-activating factor produced by a T cell hybridoma: physiochemical and biosynthetic resemblance to gamma-interferon.
J Immunol. 1983 Aug;131(2):826-32
PMID: 6408190
-
Spontaneous production of interleukin-1 by human alveolar macrophages.
Clin Immunol Immunopathol. 1983 Dec;29(3):443-50
PMID: 6605829
-
Potentiation of the cytolytic activity of peripheral blood monocytes by lymphokines and interferon.
J Immunol. 1983 Mar;130(3):1220-5
PMID: 6401781